Skip to Content

UL 125 (Divalproex Sodium Delayed Release 125 mg)

Pill with imprint UL 125 is Orange, Capsule-shape and has been identified as Divalproex Sodium Delayed Release 125 mg. It is supplied by Unichem Pharmaceuticals (USA), Inc..

Divalproex sodium is used in the treatment of bipolar disorder; epilepsy; mania; migraine prevention; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for UL 125

Divalproex Sodium Delayed Release

Imprint:
UL 125
Strength:
125 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Unichem Pharmaceuticals (USA), Inc.
National Drug Code (NDC):
29300-0138

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide